Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 14 Issue 6, June 2014

'Lighting the way' by Lara Crow, inspried by the Review on p406, which discusses intravital imaging of several hallmarks of cancer.

Research Highlight

  • Cell competition occurs in the thymus to promote natural turnover of older progenitor cells, and mice lacking such competition develop T cell acute lymphoblastic leukaemia (T-ALL).

    • Sarah Seton-Rogers
    Research Highlight

    Advertisement

Top of page ⤴

In Brief

Top of page ⤴

Research Highlight

  • Adleret al. identify PRPF6as an important driver of colon cancer cell growth and suggest it promotes proliferation by preferential splicing of growth-promoting genes.

    • Isabel Lokody
    Research Highlight
  • This paper indicates that a global loss of microRNAs reduces the growth of non-small-cell lung cancer cellsin vivoowing to the suppression of tumour angiogenesis.

    • Nicola McCarthy
    Research Highlight
  • Caswell, Chuang and colleagues trace the dissemination potential of lung tumours in mice.

    • Gemma K. Alderton
    Research Highlight
  • Scott Lowe and colleagues have found that increased expression of platelet-derived growth factor receptor-β in pancreatic cancer cells is mediated by DNA binding and structural mutants of p53 and that this contributes to metastasis.

    • Nicola McCarthy
    Research Highlight
  • The bromodomain and extraterminal (BET) family of chromatin readers are important for androgen receptor-mediated transcription, and BET inhibition by the small molecule JQ1 reduces tumour volume in a mouse model of castration-resistant prostate cancer.

    • Sarah Seton-Rogers
    Research Highlight
  • Kunyoo Shin, Philip Beachy and colleagues have tracked the development of invasive bladder cancer in mice and show that basal stem cells, which express sonic hedgehog, initiate this disease.

    • Nicola McCarthy
    Research Highlight
Top of page ⤴

In Brief

Top of page ⤴

Progress

  • The cohesin complex is involved in sister chromatid cohesion, as well as other processes, such as transcriptional regulation. Mutations in genes encoding cohesin subunits and cohesin regulators have recently been identified in several tumour types. This Progress article discusses the roles of the cohesin complex and how its mutation might contribute to cancer progression.

    • Ana Losada
    Progress
Top of page ⤴

Review Article

  • There is a clinical need for biomarkers to identify women with progressive cervical intraepithelial neoplasia (CIN) lesions to tailor clinical management and prevent overtreatment. This Review discusses the advances in understanding genetic and epigenetic alterations that underlie cervical cancer development, which offer opportunities for the molecular distinction of cervical cancer precursor lesions.

    • Renske D. M. Steenbergen
    • Peter J. F. Snijders
    • Chris J. L. M. Meijer
    Review Article
  • This Review highlights how intravital microscopy techniques have been used in living animals (predominantly mice) to unravel fundamental and dynamic aspects of several processes that are crucial for the initiation and progression of tumours, and it discusses future perspectives for these techniques.

    • Saskia I. J. Ellenbroek
    • Jacco van Rheenen
    Review Article
Top of page ⤴

Opinion

  • This Opinion article discusses emerging evidence that nicotine has tumour-promoting activities and may also have direct mutagenic effects, in addition to its effects in combination with tobacco carcinogens. The author suggests that these data should be considered in the development and evaluation of non-tobacco nicotine products.

    • Sergei A. Grando
    Opinion
  • The burden of chemotherapy-associated toxicity is well recognized, but we have relatively few tools that increase the precision of anticancer drug prescribing. This article proposes that broader agnostic analyses to systematically correlate germline genetic variants with adverse events in large, well-defined cancer populations might improve the current situation.

    • David Church
    • Rachel Kerr
    • David Kerr
    Opinion
Top of page ⤴

Search

Quick links